Industries > Pharma > Global Anaesthesia Drugs Market 2018-2028

Global Anaesthesia Drugs Market 2018-2028

Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia

PUBLISHED: 28 February 2018
PAGES: 172
PRODUCT CODE: PHA0289

Clear
WOOCS 2.2.1
SKU: PHA0289 Categories: , , Tags: ,

The global anaesthesia drugs market is expected to reach $10.5bn in 2022 and is estimated to grow at a CAGR of 3.6% from 2017 to 2028. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market and is also projected to grow at the highest CAGR during the forecast period owing to its large application in surgeries, less adverse effects, and high adoption rate.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 172-page report you will receive 104 tables and 72 figures– all unavailable elsewhere. 

The 172-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Anaesthesia Drugs Market forecasts from 2018-2028

• Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2028 for the market segmented by type:
• Local Anaesthesia Drugs
• General Anaesthesia Drugs

• This report shows forecasts to 2028 for the market segmented by route of administration:
• Inhalation Anaesthesia Drugs 
• Intravenous Anaesthesia Drugs
• Topical Anaesthesia Drugs

• Our analyses show individual revenue forecasts to 2028 for these regional and national markets:
• North America: US and Canada
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa

Each regional and national market is further segmented by type and route of administration.

Global Anaesthesia Drugs Market 2018-2028

• This report discusses the leading drugs of the global anaesthesia drugs market

• This report profiles the leading companies in the global anaesthesia drugs industry:
• Baxter International, Inc.
• AbbVie
• PAION AG
• Pfizer
• Hameln Pharmaceuticals
• AstraZeneca
• Fresenius Kabi
• Maruishi Pharmaceuticals
• Pacira Pharmaceuticals, Inc

• This report discusses promising drug candidates which are under development for the Anaesthesia drugs market.

• Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.

Visiongain’s study is intended for anyone requiring commercial analyses for the anaesthesia drugs market. You find data, trends and predictions. 

Buy our report today Global Anaesthesia Drugs Market 2018-2028: Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2018-2028


Latest Pharma news

“Global Cell Therapy Technologies market set to grow to $23bn by 2024” says new Visiongain report

Cell therapy technologies are used across various research areas including gene therapy, cancer vaccines, regenerative medicine, biologics and others. Increasing global disease burdens and the need for more personalised & precision medicine has led to massive growth in the cell technology market, which is likely to increase over the next decade.

19 February 2020

READ

“Global Asthma & COPD market set to grow to $49 bn by 2025” says new Visiongain report

The Asthma and COPD market has the potential to bring several blockbuster drugs to the marketplace due to the increasingly segmented sub-groups of patients.

17 February 2020

READ

“Global Rheumatoid Arthritis Drugs market estimated to grow at a CAGR of 0.6% in the second half of the forecast period” says Visiongain report

Another factor driving the growth in the market is the discovery of new molecules that are involved in the disease process, and hence, new strategies for treating the disease.

17 February 2020

READ

Visiongain assesses that the Contract Research Organisations (CROs) market will generate revenues of $38.0 billion in 2020

Global clinical research organizations market was valued at $34.9 billion in 2019 and is projected to grow at a CAGR of 9.5% during the forecast period 2020-2030.

12 February 2020

READ

Categories

Category